Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gieschke

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Computer Methods and Programs in Biomedicine|January 18, 2005
Explicit solutions for a class of indirect pharmacodynamic response modelsP Jordan, R Gieschke
European Journal of Drug Metabolism and Pharmacokinetics|October 14, 2000
Pharmacometrics: modelling and simulation tools to improve decision making in clinical drug developmentR Gieschke, J L Steimer
Current Drug Metabolism|November 1, 2006
Clinical utility of a pharmacostatistical model for ibandronate in postmenopausal osteoporosisJ-Y Reginster, R Gieschke
Journal of Neural Transmission. Supplementum|January 1, 1988
Interaction of moclobemide, a new reversible monoamine oxidase inhibitor with oral tyramineR Gieschke, W Schmid-Burgk, R Amrein
Journal of Neural Transmission. Supplementum|January 1, 1988
Blood pressure response to tyramine-enriched meal before and during MAO-inhibition in man: influence of dosage regimenT Müller, R Gieschke, W H Ziegler
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Interaction studies with moclobemideR Zimmer, R Gieschke, R Fischbach, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 14, 1997
Exploring clinical study design by computer simulation based on pharmacokinetic/pharmacodynamic modellingR Gieschke, B G Reigner, J L Steimer
Journal of Cardiovascular Pharmacology|December 1, 1996
Modification of the cardiovascular effects of ephedrine by the reversible monoamine oxidase A-inhibitor moclobemideJ Dingemanse, T Guentert, R Gieschke, et al.
Nuklearmedizin. Nuclear Medicine|December 1, 1983
[A nuclear medicine method for determining left ventricular stroke volume]R Gieschke, R Reuter, H R Figulla, et al.
Clinical Pharmacokinetics|August 19, 1999
Relationships between exposure to saquinavir monotherapy and antiviral response in HIV-positive patientsR Gieschke, B Fotteler, N Buss, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Computer Methods and Programs in Biomedicine|January 18, 2005
Explicit solutions for a class of indirect pharmacodynamic response modelsP Jordan, R Gieschke
European Journal of Drug Metabolism and Pharmacokinetics|October 14, 2000
Pharmacometrics: modelling and simulation tools to improve decision making in clinical drug developmentR Gieschke, J L Steimer
Current Drug Metabolism|November 1, 2006
Clinical utility of a pharmacostatistical model for ibandronate in postmenopausal osteoporosisJ-Y Reginster, R Gieschke
Journal of Neural Transmission. Supplementum|January 1, 1988
Interaction of moclobemide, a new reversible monoamine oxidase inhibitor with oral tyramineR Gieschke, W Schmid-Burgk, R Amrein
Journal of Neural Transmission. Supplementum|January 1, 1988
Blood pressure response to tyramine-enriched meal before and during MAO-inhibition in man: influence of dosage regimenT Müller, R Gieschke, W H Ziegler
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
Interaction studies with moclobemideR Zimmer, R Gieschke, R Fischbach, et al.
International Journal of Clinical Pharmacology and Therapeutics|November 14, 1997
Exploring clinical study design by computer simulation based on pharmacokinetic/pharmacodynamic modellingR Gieschke, B G Reigner, J L Steimer
Journal of Cardiovascular Pharmacology|December 1, 1996
Modification of the cardiovascular effects of ephedrine by the reversible monoamine oxidase A-inhibitor moclobemideJ Dingemanse, T Guentert, R Gieschke, et al.
Nuklearmedizin. Nuclear Medicine|December 1, 1983
[A nuclear medicine method for determining left ventricular stroke volume]R Gieschke, R Reuter, H R Figulla, et al.
Clinical Pharmacokinetics|August 19, 1999
Relationships between exposure to saquinavir monotherapy and antiviral response in HIV-positive patientsR Gieschke, B Fotteler, N Buss, et al.
Pageof 3